Tencent showcased its three core AI solutions to the world: ‘MagicDawn,’ ‘VISVISE,’ and ‘ACE.’ According to Tencent, the most ...
Phase 2 Study Demonstrated 73% clinical Clearance in the 200-µg Arm suggests that ~3 out of 4 treated lesions may allow ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results